Severe interstitial lung disease in connective tissue disease: rituximab as rescue therapy

In very severe interstitial lung disease associated with connective tissue disease (CTD-ILD), progressing despite maximal conventional immunosuppression, there is no effective medical rescue therapy. The aim of the present study was to test whether rituximab, a monoclonal antibody that depletes peri...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	The European respiratory journal 2012-09, Vol.40 (3), p.641-648
Hauptverfasser:	KEIR, Gregory J, MAHER, Toby M, HANSELL, David M, DENTON, Christopher P, ONG, Voon H, SINGH, Suveer, WELLS, Athol U, RENZONI, Elisabetta A
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Antibodies, Monoclonal, Murine-Derived - therapeutic use Biological and medical sciences Carbon Monoxide - analysis Connective Tissue Diseases - drug therapy Connective Tissue Diseases - physiopathology Female Humans Immunosuppressive Agents - therapeutic use Lung Diseases, Interstitial - drug therapy Lung Diseases, Interstitial - physiopathology Male Medical sciences Middle Aged Pneumology Respiratory Function Tests Respiratory system : syndromes and miscellaneous diseases Retrospective Studies Rituximab Severity of Illness Index
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!